Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

Abstract Background A soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4 (sCTLA‐4) is a prognostic biomarker for several cancers but remains unclear in HCC patients. The aim of study is to evaluate the predictive role of serum sCTLA‐4 levels for tumor recurrence of chronic hepatis C (CHC)‐HCC patients...

Full description

Bibliographic Details
Main Authors: Wei Teng, Wen‐Juei Jeng, Wei‐Ting Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Cancer Medicine
Subjects:
chronic hepatis C
hepatocellular carcinoma
prognosis
radiofrequency ablation
soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4
Online Access:https://doi.org/10.1002/cam4.4760

Internet

https://doi.org/10.1002/cam4.4760

Similar Items